GEN-1047

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameGEN-1047

Drug Alias NameGEN-1047

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionV-set domain-containing T-cell activation inhibitor 1 inhibitorsAnti-CD3

TargetsV-set domain-containing T-cell activation inhibitor 1T cell surface glycoprotein CD3

Therapy Area/IndicationsEndometrial Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesPoland +[9]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGenmab A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenmab A/S

Active IndicationsN/A

Inactive IndicationsEndometrial Neoplasms

Other Information

ATC CodeN/A